Chemed CHE Excess tax benefits associated with employee equity plans
Excess tax benefits associated with employee equity plans at other companies
Other financials
Where this comes from
Reported directly by Chemed in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount.
The official record: Chemed’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Chemed's excess tax benefits associated with employee equity plans.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Chemed's excess tax benefits associated with employee equity plans?
- Chemed (CHE) reported excess tax benefits associated with employee equity plans of 69,600,000% in Q4 2025.
- How has Chemed's excess tax benefits associated with employee equity plans changed year-over-year?
- Chemed's excess tax benefits associated with employee equity plans increased by 115.7% year-over-year, from -444,200,000% to 69,600,000%.
- What is the long-term trend for Chemed's excess tax benefits associated with employee equity plans?
- Over 3 years (2021 to 2024), Chemed's excess tax benefits associated with employee equity plans has grown at a -79.5% compound annual growth rate (CAGR), from 1,516,800,000% to -13,100,000%.
- What does excess tax benefits associated with employee equity plans mean?
- Quantifies the tax benefit realized from share-based compensation arrangements, such as stock options or restricted stock units. This benefit arises when the tax deduction for equity awards exceeds the compensation expense recognized for financial reporting. It serves as a measure of the tax-shielding impact of employee equity incentives.